When Will We Reach Herd Immunity?

Dr. Andrea Klemes, Chief Medical Officer MDVIP
By Dr. Andrea Klemes , MDVIP
April 8, 2021
COVID Herd Immunity

Since the COVID-19 pandemic began a year ago, a lot of pundits, experts and epidemiologists have been talking about herd immunity. Herd immunity occurs when a high percentage of a population achieves immunity to a disease, either through exposure or vaccination, making spread of the disease unlikely, even among those who are not immune.
We hope that if we can achieve herd immunity, we’ll be able to go back to normal. But some scientists are uncertain that herd immunity is achievable for this coronavirus and a lot is up for a lot of debate.

What Constitutes Herd Immunity?

Herd immunity is important for a variety of reasons:

  • It protects those who have not yet developed immunity and those who can’t get a vaccine for health reasons.
  • It slows or stops the spread of a disease.
  • It can limit the opportunity for viruses to mutate.

A lot of numbers have been thrown around as to what constitutes herd immunity. Diseases vary, but generally, scientists estimate that 70 to 90 percent of the population needs to have immunity to a virus or communicable disease before someone without immunity is unlikely to become infected, according to a government report. Measles, which is more communicable than the coronavirus that causes COVID-19, requires a herd immunity threshold of 95 percent. For polio, which has a similar transmission rate as SARS-CoV-2, the threshold is about 80 percent, according to the World Health Organization.

So, what’s the herd immunity threshold for SARS-CoV-2? That’s been hard to pin down. We still only know so much about the disease — its communicability is really an estimate versus diseases like measles that we’ve had decades to research. Still, the 70 to 90 percent estimate is one that government health experts keep suggesting.

What Will It Take to Reach Herd Immunity?

For the coronavirus we’re currently fighting, herd immunity will probably only be reached when the vast majority of people get a vaccine (people who’ve had the disease develop some immunity and count towards herd immunity, but due to limited testing and asymptomatic cases, we don’t really know how many people in the U.S. have had COVID-19). We have a long ways to go on vaccines, but we’re making steady progress. At the end of March, about 25 percent of Americans had gotten at least one dose of a COVID vaccine (70 percent of those 65 years and older had at least one shot), according to the Centers for Disease Control and Prevention.

That number is expected to increase dramatically in the next few months, and all Americans 16 and older who want the vaccine are expected to be able to get the vaccine by this summer. One site tracking vaccinations and infections estimates that 60 to 70 percent of the U.S. population will have at least one dose of the vaccine by the end of 2021. Around 30 percent will have been infected by the virus and will achieve some natural immunity.

While that sounds like we’ll be close to the herd immunity threshold in the U.S. by the end of the year (even if there’s overlap in the two groups), there are some caveats to consider:

  • A large group of Americans remain unvaccinated: Children. There are more than 60 million Americans that are too young to receive the vaccines currently authorized by the Food and Drug Administration. Vaccines are in testing for children under 16, but most experts do not expect availability until August.
  • There is still some vaccine hesitancy. A Carnegie Mellon University survey released in March found that up to 77 percent of adults are willing to get vaccinated or already are. This acceptance is higher than other studies (an earlier Pew Research study pegged the number willing to get vaccinated or are already vaccinated at 69 percent), but most surveys are trending the right direction. Still, some groups remain more hesitant than others.
  • Vaccine rollout remains uneven. This problem should solve itself by the summer in the United States, but we’re a connected planet. Some countries haven’t begun vaccinations at all and others are just now beginning vaccination efforts.
  • We don’t know how long immunity will last, either natural or from the vaccines.

How Can We Help Reach Herd Immunity?

Even though we face headwinds, there are things we can do to move closer to the herd immunity threshold. First, get your vaccine when it becomes available to you. Don’t shop around for one versus another.
Second, encourage your loved ones to do the same.

In the meantime, continue to follow CDC guidelines, even if you’re vaccinated, to limit spread of the disease. We’re in this fight together. We’re all part of the same herd.

Similar Posts

About the Author
Dr. Andrea Klemes, Chief Medical Officer MDVIP
Dr. Andrea Klemes, MDVIP

Dr. Andrea Klemes is the Chief Medical Officer of MDVIP. She also serves as the executive and organizational leader of MDVIP’s Medical Advisory Board that supports quality and innovation in the delivery of the healthcare model drawing expertise from the affiliated physicians. Dr. Klemes oversees MDVIP’s impressive outcomes data and research including hospital utilization and readmission statistics, quality of disease management in the MDVIP network and the ability to identify high-risk patients and intervene early. She is instrumental in the adoption of the Electronic Health Record use in MDVIP-affiliated practices and the creation of the data warehouse. Dr. Klemes is board certified in internal medicine and endocrinology and a fellow of the American College of Endocrinology. Dr. Klemes received her medical degree from the New York College of Osteopathic Medicine. She completed an internal medicine residency at Cabrini Medical Center in Manhattan, New York and an Endocrine and Metabolism Fellowship at the Medical College of Georgia in Augusta. Prior to joining MDVIP, Dr. Klemes worked at Procter & Gamble in the areas of personal healthcare, women’s health and digestive wellness and served as North American Medical Director for bone health. She spent 10 years in private practice specializing in endocrinology and metabolism in Tallahassee, Florida. In addition, Dr. Klemes held leadership roles with the American Medical Association, Florida Medical Association and as Medical Director of the Diabetes Center in Tallahassee and Panama City, Florida, as well as Chief of the Department of Medicine at Tallahassee Community Hospital. She has been a consultant and frequent lecturer and has completed broad clinical research in diabetes and osteoporosis and published extensively.

View All Posts By Dr. Andrea Klemes
Physician Locator
Enter a full address, city, state, or ZIP code. You can also browse our city directory to find physicians in your area.
Enter Doctor's Name